This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

SGLT2i Versus DPP-4i as an Add-On Therapy and the Risk of PAD-Related Surgical Events

Ertugliflozin Lowers Uric Acid and Reduces Gout Risk in Type 2 Diabetes Patients with CVD, VERTIS CV...

Canada: Recent post hoc analyses from the VERTIS CV trial reveal promising results for ertugliflozin, a medication used to manage type 2 diabetes. The...
View All

Latest News and Guidelines

Bariatric Surgery Surpasses GLP-1 Diabetes Medication in Progression of Chronic Kidney Disease, shows Cleveland Clinic Study

Bariatric Surgery Surpasses GLP-1 Diabetes Medication in Progression of Chronic Kidney Disease,...

Rare Disease Show Episode 15 : Understanding Congenital Hyperinsulinism with Dr Srinath Aswathiah

Rare Disease Show Episode 15 : Understanding Congenital Hyperinsulinism with Dr Srinath Aswathiah

Dulaglutide Offers Dual Benefits for Elderly: Improved Blood Sugar Control and Knee OA Pain Relief, Study Finds

Dulaglutide Offers Dual Benefits for Elderly: Improved Blood Sugar Control and Knee OA Pain Relief,...

bariatric surgery

Bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection suggests Cleveland Clinic...

CDSCO Committee Recommends SpinoS to Conduct BE Study with Vitamin D Screening Conditions

Vitamin D may improve insulin resistance already present at time of prediabetes, reveals research

Neuropathy Impact on Outcomes and Efficacy in HF Patients with Type 2 Diabetes: Insights from DAPA-HF and DELIVER Trials

Neuropathy Impact on Outcomes and Efficacy in HF Patients with Type 2 Diabetes: Insights from...

View All
X